Liability Risk and Insurance
Blow to GSK on Paxil claims
A ruling by Judge Mariana Pfaelzer of US Federal Court in Los Angeles has banned GlaxoSmithkline’s (GSK) adverts for anti-depressant
drug Paxil (known as Seroxat in Europe) for the duration of a class action alleging that it is addictive. The adverts, which
had been cleared by the Food & Drug Administration, claim that it is ‘non-habit-forming’.